Intravesical bacillus Calmette-Guerin (BCG) therapy for superficial bladder carcinoma Yüzeyel mesane tümorleri̇nde i̇ntravezi̇kal BCG uygulamasi
Gulhane Medical Journal, cilt.44, sa.1, ss.106-112, 2002 (Scopus, TRDizin)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 44 Sayı: 1
- Basım Tarihi: 2002
- Dergi Adı: Gulhane Medical Journal
- Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.106-112
- Anahtar Kelimeler: BCG, Intravesical therapy, Superficial bladder cancer
- Sağlık Bilimleri Üniversitesi Adresli: Hayır
Özet
Eighty percent of bladder tumors are confined to mucosa (CIS, Ta) or submucosa (T1) at initial presentation. The main problems in superficial bladder cancer are recurrence and progression in spite of resection. To prevent these, several intravesical agents are used. The most effective of these agents is bacillus Calmette-Guerin (BCG). But the questions about its mechanism, optimal dose and clinical use remain unclear.